SMTL ID : 8exl.1

Crystal structure of PI3K-alpha in complex with taselisib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.99 Å

Oligo State

monomer

Ligands

1 x 799: 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1H-pyrazol-1-yl)propanamide(Non-covalent)

799.1: 20 residues within 4Å: Chain A: R.798, S.802, P.806, W.808, I.828, K.830, D.838, Y.864, I.876, E.877, V.878, V.879, N.881, S.882, H.883, Q.887, M.950, F.958, I.960, D.961 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:P.806, A:W.808, A:I.828, A:V.878 Hydrogen bonds: A:V.879, A:N.881, A:S.882, A:S.882, A:Q.887, A:D.961 pi-Stacking: A:W.808

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hanan, E.J. et al., Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3K alpha. J.Med.Chem. (2022)

Release Date

2022-11-30

Peptides

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

Related Entries With Identical Sequence